N-(4-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)phenyl)-N-(4-(trifluoromethyl)phenyl)cyclopropane-1,1-dicarboxamide

ID: ALA4549013

PubChem CID: 155549541

Max Phase: Preclinical

Molecular Formula: C33H28F5N7O2

Molecular Weight: 649.62

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1nc2c(F)cc(-c3nc(Nc4ccc(NC(=O)C5(C(=O)Nc6ccc(C(F)(F)F)cc6)CC5)cc4)ncc3F)cc2n1C(C)C

Standard InChI:  InChI=1S/C33H28F5N7O2/c1-17(2)45-18(3)40-28-24(34)14-19(15-26(28)45)27-25(35)16-39-31(44-27)43-23-10-8-22(9-11-23)42-30(47)32(12-13-32)29(46)41-21-6-4-20(5-7-21)33(36,37)38/h4-11,14-17H,12-13H2,1-3H3,(H,41,46)(H,42,47)(H,39,43,44)

Standard InChI Key:  HVDWBKWKMSTGLU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 47 52  0  0  0  0  0  0  0  0999 V2000
    7.4084   -4.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0039   -4.0860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5949   -4.7891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4655   -2.8643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4643   -3.6838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1724   -4.0928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8820   -3.6833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8792   -2.8607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1706   -2.4554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5904   -4.0908    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2974   -3.6811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2961   -2.8639    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7128   -3.6789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4212   -4.0864    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7116   -2.8617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1283   -3.6767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8338   -4.0843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5404   -3.6753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5395   -2.8573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8262   -2.4499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1225   -2.8613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2460   -2.4466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9549   -2.8532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9521   -3.6702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6601   -4.0767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3676   -3.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3626   -2.8445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6540   -2.4418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0771   -4.0715    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.6621   -4.8938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9559   -5.3010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9575   -6.1174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3706   -5.2953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3758   -6.1104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6692   -6.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8488   -7.3300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6664   -7.4069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9919   -6.6531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7893   -6.4744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3428   -7.0756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0333   -5.6944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0828   -8.1100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2501   -6.5265    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.7576   -2.4558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7574   -1.6386    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.0500   -2.8646    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.0471   -2.0471    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  7 10  1  0
 10 11  1  0
 11  2  1  0
 11 12  2  0
  2 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
 25 30  1  0
 30 31  2  0
 31 32  1  0
 32 35  2  0
 34 33  2  0
 33 30  1  0
 34 35  1  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 34  1  0
 38 39  1  0
 39 40  1  0
 39 41  1  0
 37 42  1  0
 32 43  1  0
  4 44  1  0
 44 45  1  0
 44 46  1  0
 44 47  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4549013

    ---

Associated Targets(Human)

CDK4 Tclin CDK4/Cyclin D3 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 649.62Molecular Weight (Monoisotopic): 649.2225AlogP: 7.78#Rotatable Bonds: 8
Polar Surface Area: 113.83Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.20CX Basic pKa: 4.33CX LogP: 6.97CX LogD: 6.97
Aromatic Rings: 5Heavy Atoms: 47QED Weighted: 0.12Np Likeness Score: -1.22

References

1. Huang Z, Zhao B, Qin Z, Li Y, Wang T, Zhou W, Zheng J, Yang S, Shi Y, Fan Y, Xiang R..  (2019)  Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.,  181  [PMID:31382120] [10.1016/j.ejmech.2019.07.044]

Source